Ethyl 3-(2-amino-5-bromopyridin-3-yl)acrylate

Catalog No. :
ACXMZV243
CAS No. :
943419-35-0
Molecular Formula :
C10H11BrN2O2
Molecular Weight :
271.11

IUPAC Name:ethyl (E)-3-(2-amino-5-bromopyridin-3-yl)acrylate

Ethyl 3-(2-amino-5-bromopyridin-3-yl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$55.00Login to see priceIn stockInquiry
250mg97%$109.00Login to see priceIn stockInquiry
1g97%$209.00Login to see priceIn stockInquiry
5g97%$966.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-(2-amino-5-bromopyridin-3-yl)acrylate
IUPAC Nameethyl (E)-3-(2-amino-5-bromopyridin-3-yl)acrylate
MDL No.MFCD08061350
Molecular FormulaC10H11BrN2O2
Molecular Weight271.11
SMILESO=C(OCC)/C=C/C1=CC(Br)=CN=C1N
InChI KeyHSKGBWXXHWXUPV-ONEGZZNKSA-N
SynonymReaxys ID: 23782191;Ethyl (E)-3-(2-amino-5-bromopyridin-3-yl)acrylate;2-Propenoic acid, 3-(2-amino-5-bromo-3-pyridinyl)-, ethyl ester
CAS No.943419-35-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXMZV243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAFDO578 route compound structure diagram
    ACAFDO57835486-42-1 In Stock
  4. Then
  5. ACXMZV243 route product structure diagram
    ACXMZV243943419-35-0 In Stock
Inquiry

2. ACXMZV243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMWAR230 route compound structure diagram
    ACMWAR230206997-15-1 In Stock
  4. Then
  5. ACXMZV243 route product structure diagram
    ACXMZV243943419-35-0 In Stock
Inquiry

Comments (0)